packageSunitinib

sunitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sunitinib is a protein kinase inhibitor used to treat several cancers, including kidney cancer, gastrointestinal stromal tumors, and neuroendocrine tumors. It is an approved medicine, authorised in the European Union, and widely used in cancer care.

Summary written by glm-5.3-flash from Wikidata Q417542 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sunitinib
ATC codes:L01EX01
DrugBank:DB01268
PubChem CID:5329102
ChEBI:38940
Wikidata:Q417542
formula:C22H27FN4O2
molar mass:398.482 g/mol (PubChem CID 5329102)
logP:2.6 (Drugs.Common 25.09, not verified)

Metabolites

SU12662SU12662370.428 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
SU12662metabolite: SU12662